Literature DB >> 25399940

Kawasaki disease.

Robert P Sundel1.   

Abstract

Kawasaki disease (KD) is the archetypal pediatric vasculitis, exemplifying the unique aspects and challenges of vascular inflammation in children. The condition is almost unheard of in adults, is closely associated with infections, and is self-limited, with fever resolving after an average of 12 days even without treatment. Yet KD is also a potentially fatal disease and the most common cause of acquired heart disease in the developed world. Unraveling of the developmental, immunologic, and genetic secrets of Kawasaki disease promises to improve our understanding of vasculitis in particular, and perhaps also to provide a window on the fundamental mysteries of inflammatory diseases in general.

Entities:  

Keywords:  Coronary artery aneurysm; Intravenous immunoglobulin; Kawasaki disease; Vascular inflammation; Vasculitis

Mesh:

Substances:

Year:  2015        PMID: 25399940     DOI: 10.1016/j.rdc.2014.09.010

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  31 in total

1.  The first case of Kawasaki disease in a 20-month old baby following immunization with rotavirus vaccine and hepatitis A vaccine in China: A case report.

Authors:  Shi Yin; Peng Liubao; Tan Chongqing; Wan Xiaomin
Journal:  Hum Vaccin Immunother       Date:  2015-07-09       Impact factor: 3.452

2.  Bifidobacterium plays a protective role in TNF-α-induced inflammatory response in Caco-2 cell through NF-κB and p38MAPK pathways.

Authors:  Nana Nie; Cui Bai; Shanai Song; Yanyan Zhang; Benzhen Wang; Zipu Li
Journal:  Mol Cell Biochem       Date:  2019-11-18       Impact factor: 3.396

3.  Retrospective study of the course, treatment and long-term follow-up of Kawasaki disease: a single-center experience from Poland.

Authors:  Aleksandra Stasiak; Elżbieta Smolewska
Journal:  Rheumatol Int       Date:  2019-03-22       Impact factor: 2.631

Review 4.  Recent Advances in Pediatric Vasculitis.

Authors:  Laura Cannon; Eveline Y Wu
Journal:  Rheum Dis Clin North Am       Date:  2021-08-27       Impact factor: 2.032

Review 5.  Diagnostic approach and current treatment options in childhood vasculitis.

Authors:  Kenan Barut; Sezgin Şahin; Amra Adroviç; Özgür Kasapçopur
Journal:  Turk Pediatri Ars       Date:  2015-12-01

Review 6.  Linking classification and therapeutic management of vasculitides.

Authors:  Corisande Baldwin; Simon Carette; Christian Pagnoux
Journal:  Arthritis Res Ther       Date:  2015-06-02       Impact factor: 5.156

7.  Spontaneous duodenal perforation as a complication of kawasaki disease.

Authors:  Kambiz Masoumi; Arash Forouzan; Hossein Saidi; Hazhir Javaherizadeh; Ali Khavanin; Mohammad Bahadoram
Journal:  Case Rep Pediatr       Date:  2015-03-26

8.  Kawasaki disease associated with Mycoplasma pneumoniae.

Authors:  Yunjia Tang; Wenhua Yan; Ling Sun; Jie Huang; Weiguo Qian; Miao Hou; Haitao Lv
Journal:  Ital J Pediatr       Date:  2016-09-08       Impact factor: 2.638

9.  Uveitis as an important ocular sign to help early diagnosis in Kawasaki disease.

Authors:  Han Seul Choi; Seul Bee Lee; Jung Hyun Kwon; Hae Soon Kim; Sejung Sohn; Young Mi Hong
Journal:  Korean J Pediatr       Date:  2015-10-21

10.  Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2.

Authors:  Caroline Diorio; Sarah E Henrickson; Laura A Vella; Kevin O McNerney; Julie Chase; Chakkapong Burudpakdee; Jessica H Lee; Cristina Jasen; Fran Balamuth; David M Barrett; Brenda L Banwell; Kathrin M Bernt; Allison M Blatz; Kathleen Chiotos; Brian T Fisher; Julie C Fitzgerald; Jeffrey S Gerber; Kandace Gollomp; Christopher Gray; Stephan A Grupp; Rebecca M Harris; Todd J Kilbaugh; Audrey R Odom John; Michele Lambert; Emily J Liebling; Michele E Paessler; Whitney Petrosa; Charles Phillips; Anne F Reilly; Neil D Romberg; Alix Seif; Deborah A Sesok-Pizzini; Kathleen E Sullivan; Julie Vardaro; Edward M Behrens; David T Teachey; Hamid Bassiri
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.